California Nanotechnologies Corp (TSE:CNO)
:CNO
Want to see TSE:CNO full AI Analyst Report?
Top Page
California Nanotechnologies
(CNO)
Select Model
Select Model
Rating:42Neutral
Price Target:
C$0.25
▼(-26.47% Downside)
Action:Reiterated
Date:02/01/26
The score is held down primarily by weak recent financial performance (declining revenue, losses, higher leverage, and negative free cash flow). Technicals are also bearish with the stock below major moving averages, partially offset by oversold momentum readings. Valuation offers limited support because the negative P/E reflects ongoing losses and there is no dividend yield.
Positive Factors
Specialized manufacturing & services
CNO's business model centers on niche, technical manufacturing and process development for nanostructured and specialty metal powders. These engineering services create higher switching costs, technical barriers and long sales cycles that support durable customer relationships and margin resilience.
Negative Factors
Sharp revenue decline
A 31.8% TTM revenue decline materially reduces scale and dilutes fixed-cost absorption, worsening unit economics. Sustained top-line weakness undermines the company's ability to cover operating leverage, threatening long-term margin recovery and investment in process development.
Read all positive and negative factors
Positive Factors
Negative Factors
Specialized manufacturing & services
CNO's business model centers on niche, technical manufacturing and process development for nanostructured and specialty metal powders. These engineering services create higher switching costs, technical barriers and long sales cycles that support durable customer relationships and margin resilience.
Read all positive factors
California Nanotechnologies (CNO) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$12.93M
Dividend YieldN/A
Average Volume (3M)35.75K
Price to Earnings (P/E)―
Beta (1Y)3.54
Revenue Growth-48.43%
EPS Growth-757.33%
CountryCA
Employees20
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)-0.05
Shares Outstanding47,875,770
10 Day Avg. Volume35,432
30 Day Avg. Volume35,752
Financial Highlights & Ratios
PEG Ratio0.94
Price to Book (P/B)8.69
Price to Sales (P/S)3.23
P/FCF Ratio25.26
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.05
Revenue Forecast (FY)C$3.14M
California Nanotechnologies Business Overview & Revenue Model
Company Description
California Nanotechnologies Corp. is dedicated to the research, advancement, and manufacturing of nanocrystalline materials, primarily achieved through the reduction of grain size. The company offers a comprehensive array of advanced material proc...
How the Company Makes Money
null...
California Nanotechnologies Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
38
Negative
Cash Flow
24
Negative
| Breakdown | TTM | May 2025 | May 2024 | May 2022 | May 2021 | May 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.04M | 6.22M | 3.34M | 1.82M | 1.06M | 1.10M |
| Gross Profit | 1.22M | 4.59M | 2.33M | 669.57K | 439.97K | 523.36K |
| EBITDA | -312.20K | 780.97K | 753.02K | 337.91K | 10.77K | 141.12K |
| Net Income | -2.15M | -158.33K | 381.68K | 79.76K | -161.40K | -74.36K |
Balance Sheet | ||||||
| Total Assets | 4.11M | 5.50M | 2.36M | 1.41M | 587.40K | 864.54K |
| Cash, Cash Equivalents and Short-Term Investments | 340.66K | 533.85K | 841.35K | 294.13K | 25.29K | 56.31K |
| Total Debt | 2.46M | 1.62M | 1.21M | 1.94M | 1.94M | 2.31M |
| Total Liabilities | 1.98M | 3.19M | 2.21M | 2.70M | 2.24M | 2.47M |
| Stockholders Equity | 2.13M | 2.32M | 145.97K | -1.29M | -1.66M | -1.61M |
Cash Flow | ||||||
| Free Cash Flow | -129.01K | 797.00K | 89.98K | 604.26K | 33.20K | 180.62K |
| Operating Cash Flow | -9.28K | 2.92M | 104.28K | 717.01K | 33.20K | 180.62K |
| Investing Cash Flow | -111.05K | -2.11M | -14.30K | -112.75K | 0.00 | 0.00 |
| Financing Cash Flow | 85.84K | -1.12M | 535.33K | -387.83K | -62.52K | -149.61K |
California Nanotechnologies Technical Analysis
Positive
0.34
Price Trends
0.25
Positive
0.27
Negative
0.32
Negative
Market Momentum
<0.01
Negative
58.88
Neutral
83.33
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CNO, the sentiment is Positive. The current price of 0.34 is above the 20-day moving average (MA) of 0.25, above the 50-day MA of 0.25, and above the 200-day MA of 0.32, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 58.88 is Neutral, neither overbought nor oversold. The STOCH value of 83.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:CNO.
California Nanotechnologies Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
51 Neutral | C$288.15M | -11.36 | -475.00% | ― | 77.39% | -226.10% | |
49 Neutral | C$190.17M | -21.47 | -5.18% | 3.12% | 4.94% | 60.87% | |
46 Neutral | C$95.83M | -6.50 | -69.66% | ― | ― | 12.74% | |
45 Neutral | C$5.76M | -15.08 | ― | ― | ― | 10.57% | |
42 Neutral | C$12.93M | -4.23 | -86.94% | ― | -48.43% | -757.33% |
* General Sector Average
TSE:CNO
California Nanotechnologies
0.27
-0.25
-48.08%
TSE:BOS
Airboss of America
7.00
2.42
52.94%
TSE:NANO
Nano One Materials
0.80
0.11
15.94%
TSE:GMG
Graphene Manufacturing Group Ltd
2.31
1.67
260.94%
TSE:SURE
SureNano Science Ltd
0.17
>-0.01
-5.56%
California Nanotechnologies Corporate Events
Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance
California Nanotechnologies Raises $935,900 in Non-Brokered Private Placement
Positive
Mar 24, 2026
California Nanotechnologies has closed a non-brokered private placement, issuing 3,119,666 units at CA$0.30 each for gross proceeds of about $935,900, with each unit including a common share and a warrant exercisable at US$0.30 for 18 months. The ...
Business Operations and StrategyPrivate Placements and Financing
California Nanotechnologies Launches Private Placement to Bolster Working Capital
Positive
Feb 24, 2026
California Nanotechnologies plans to raise up to CA$750,000 through a non-brokered private placement of 2,500,000 units priced at CA$0.30, each comprising one common share and one warrant exercisable at US$0.30 for 18 months. The company has also ...
Business Operations and StrategyFinancial Disclosures
California Nanotechnologies Hit by Revenue Slump but Sees Q4 Rebound and Defense, Nuclear Growth
Negative
Jan 29, 2026
California Nanotechnologies reported a sharp downturn in its third quarter of fiscal 2026, with revenues falling 78% year over year to US$392,481 and swinging to a net loss of US$1.09 million, largely due to delayed manufacturing service revenues,...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.